{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:10Z","timestamp":1790634850248,"version":"4.1.0"},"reference-count":81,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1136\/bjophthalmol-2015-306972","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T01:27:04Z","timestamp":1447118824000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":64,"title":["Current therapeutic developments in atrophic age-related macular degeneration"],"prefix":"10.1136","volume":"100","author":[{"given":"Jakub","family":"Hanus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-306972-1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key-10.1136\/bjophthalmol-2015-306972-2","volume-title":"The Global economic cost of visual impairment","author":"Gordois","year":"2010"},{"key":"key-10.1136\/bjophthalmol-2015-306972-3","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMra062326","article-title":"Age-related macular degeneration","volume":"355","author":"de Jong","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306972-6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3928\/23258160-20150101-01","article-title":"Geographic atrophy: clinical impact and emerging treatments","volume":"46","author":"Patel","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2015-306972-7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-9","doi-asserted-by":"crossref","first-page":"319728","DOI":"10.1155\/2012\/319728","article-title":"Antivascular endothelial growth factor agents for neovascular age-related macular degeneration","volume":"2012","author":"Zampros","year":"2012","journal-title":"J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2015-306972-11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-13","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1017\/S146239941000164X","article-title":"Oxidation and age-related macular degeneration: insights from molecular biology","volume":"12","author":"Khandhadia","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-14","doi-asserted-by":"crossref","first-page":"e965","DOI":"10.1038\/cddis.2013.478","article-title":"Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells","volume":"4","author":"Hanus","year":"2013","journal-title":"Cell Death Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306972-15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2353\/ajpath.2008.070730","article-title":"Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice","volume":"172","author":"Hashizume","year":"2008","journal-title":"Am J Pathol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-16","doi-asserted-by":"crossref","first-page":"e19456","DOI":"10.1371\/journal.pone.0019456","article-title":"Age-related retinopathy in NRF2-deficient mice","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2015-306972-17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2008.10.001","article-title":"Molecular pathology of age-related macular degeneration","volume":"28","author":"Ding","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-306972-18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/ppa.12.12","article-title":"Next-generation therapeutic solutions for age-related macular degeneration","volume":"1","author":"Cunnusamy","year":"2012","journal-title":"Pharm Pat Anal"},{"key":"key-10.1136\/bjophthalmol-2015-306972-19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/08820538.2011.570849","article-title":"Inflammation and age-related macular degeneration (AMD)","volume":"26","author":"Telander","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-20","doi-asserted-by":"crossref","first-page":"802059","DOI":"10.1155\/2011\/802059","article-title":"Lipids, lipoproteins, and age-related macular degeneration","volume":"2011","author":"Ebrahimi","year":"2011","journal-title":"J Lipids"},{"key":"key-10.1136\/bjophthalmol-2015-306972-21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-306972-22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-306972-23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-306972-24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-306972-25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4419-5635-4_2","article-title":"The role of complement in AMD","volume":"703","author":"Zipfel","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-27","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306972-29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/23258160-20131217-01","article-title":"Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration","volume":"45","author":"Garcia Filho","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.1136\/bjophthalmol-2015-306972-30","unstructured":"http:\/\/www.ophthotech.com\/product-candidates\/"},{"key":"key-10.1136\/bjophthalmol-2015-306972-31","unstructured":"http:\/\/www.roche.com\/investors\/updates\/inv-update-2013-08-27.htm"},{"issue":"(3 Suppl)","key":"key-10.1136\/bjophthalmol-2015-306972-32","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1016\/S0041-1345(03)00356-7","article-title":"The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation","volume":"35","author":"Camardo","year":"2003","journal-title":"Transplantation proceedings"},{"key":"key-10.1136\/bjophthalmol-2015-306972-33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"key-10.1136\/bjophthalmol-2015-306972-34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.18632\/aging.100070","article-title":"mTOR's role in ageing: protein synthesis or autophagy?","volume":"1","author":"Hands","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"key-10.1136\/bjophthalmol-2015-306972-35","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1167\/iovs.13-11650","article-title":"Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I\/II clinical trial","volume":"54","author":"Wong","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2014.05.005","article-title":"Immunomodulation neuroprotection and remyelination\u2014the fundamental therapeutic effects of glatiramer acetate: a critical review","volume":"54","author":"Aharoni","year":"2014","journal-title":"J Autoimmun"},{"key":"key-10.1136\/bjophthalmol-2015-306972-37","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2741\/4033","article-title":"Oxidative stress: the Achilles\u2019 heel of neurodegenerative diseases of the retina","volume":"17","author":"Cai","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key-10.1136\/bjophthalmol-2015-306972-38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm1709","article-title":"Oxidative damage-induced inflammation initiates age-related macular degeneration","volume":"14","author":"Hollyfield","year":"2008","journal-title":"Nat Med"},{"key":"key-10.1136\/bjophthalmol-2015-306972-39","first-page":"772","article-title":"Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration","volume":"13","author":"Suzuki","year":"2007","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2015-306972-40","first-page":"184","article-title":"Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas","volume":"9","author":"Dentchev","year":"2003","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2015-306972-41","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-42","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","article-title":"Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35","volume":"120","author":"Chew","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306972-43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-44","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3945\/ajcn.2009.27594","article-title":"{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study","volume":"90","author":"Sangiovanni","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"key-10.1136\/bjophthalmol-2015-306972-45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2010.04.012","article-title":"Protection of retinal pigment epithelium by OT-551 and its metabolite TEMPOL-H against light-induced damage in rats","volume":"91","author":"Tanito","year":"2010","journal-title":"Exp Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-306972-46","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1167\/iovs.10-5637","article-title":"Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial","volume":"51","author":"Wong","year":"2010","journal-title":"Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2014.12.038","article-title":"MRZ-99030\u2014A novel modulator of Abeta aggregation: I\u2014Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)","volume":"92","author":"Parsons","year":"2015","journal-title":"Neuropharmacology"},{"key":"key-10.1136\/bjophthalmol-2015-306972-48","unstructured":"http:\/\/www.reviewofophthalmology.com\/content\/d\/retinal_insider\/c\/44883\/"},{"key":"key-10.1136\/bjophthalmol-2015-306972-49","first-page":"1051","article-title":"Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration","volume":"42","author":"Holz","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-50","first-page":"478","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope","volume":"38","author":"von Ruckmann","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-51","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1167\/iovs.03-0172","article-title":"Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium","volume":"44","author":"Schutt","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-52","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1074\/jbc.270.32.18825","article-title":"Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species","volume":"270","author":"Rozanowska","year":"1995","journal-title":"J Biol Chem"},{"key":"key-10.1136\/bjophthalmol-2015-306972-53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1167\/iovs.03-0277","article-title":"Age-related changes in the photoreactivity of retinal lipofuscin granules: role of chloroform-insoluble components","volume":"45","author":"Rozanowska","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1475-2859-8-21","article-title":"Medical bioremediation of age-related diseases","volume":"8","author":"Mathieu","year":"2009","journal-title":"Microb Cell Fact"},{"key":"key-10.1136\/bjophthalmol-2015-306972-55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/ICU.0b013e32832af468","article-title":"The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration","volume":"20","author":"Javitt","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-56","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1167\/iovs.05-0820","article-title":"Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases","volume":"46","author":"Radu","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IAE.0b013e318265801d","article-title":"Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration","volume":"33","author":"Mata","year":"2013","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2015-306972-58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/IAE.0b013e318217369e","article-title":"Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator","volume":"32","author":"Kubota","year":"2012","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2015-306972-59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.iae.0000434565.80060.f8","article-title":"Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers","volume":"34","author":"Kubota","year":"2014","journal-title":"Retina (Philadelphia, Pa)"},{"key":"key-10.1136\/bjophthalmol-2015-306972-60","unstructured":"http:\/\/www.ffb.ca\/research\/research_news\/Alkeus_Stargardt.html"},{"key":"key-10.1136\/bjophthalmol-2015-306972-61","unstructured":"http:\/\/www.alkeuspharma.com\/preclinical.html"},{"key":"key-10.1136\/bjophthalmol-2015-306972-62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch's membrane","volume":"29","author":"Booij","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-306972-63","unstructured":"Chiou G . Is dry AMD treatable? A new ophthalmic solution may halt disease progression. Retina Today 2012:69\u201379."},{"key":"key-10.1136\/bjophthalmol-2015-306972-64","first-page":"324","article-title":"Effects of hydralazine on ocular blood flow and laser-induced choroidal neovascularization","volume":"2","author":"Wei Jiang","year":"2009","journal-title":"Int J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-65","first-page":"324","article-title":"Effects of hydralazine on ocular blood flow laser-induced choroidal neovascularization","volume":"2","author":"Jiang","year":"2009","journal-title":"Int J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-66","volume-title":"Age-related Macular Degeneration","author":"Holz","year":"2012"},{"key":"key-10.1136\/bjophthalmol-2015-306972-67","doi-asserted-by":"crossref","first-page":"e8152","DOI":"10.1371\/journal.pone.0008152","article-title":"Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat","volume":"4","author":"Carr","year":"2009","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2015-306972-68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.scr.2012.05.002","article-title":"Generation of retinal pigment epithelial cells from human embryonic stem cell-derived spherical neural masses","volume":"9","author":"Cho","year":"2012","journal-title":"Stem Cell Res"},{"key":"key-10.1136\/bjophthalmol-2015-306972-69","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/stem.189","article-title":"Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells","volume":"27","author":"Buchholz","year":"2009","journal-title":"Stem Cells"},{"key":"key-10.1136\/bjophthalmol-2015-306972-70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/stem.635","article-title":"Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE","volume":"29","author":"Kokkinaki","year":"2011","journal-title":"Stem Cells"},{"key":"key-10.1136\/bjophthalmol-2015-306972-71","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1167\/iovs.10-6413","article-title":"Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival","volume":"52","author":"Zhu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.expneurol.2008.09.007","article-title":"Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation","volume":"214","author":"Vugler","year":"2008","journal-title":"Exp Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-73","first-page":"283","article-title":"Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay","volume":"15","author":"Carr","year":"2009","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2015-306972-74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells1040851","article-title":"Recent advances towards the clinical application of stem cells for retinal regeneration","volume":"1","author":"Becker","year":"2012","journal-title":"Cells"},{"key":"key-10.1136\/bjophthalmol-2015-306972-75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"key-10.1136\/bjophthalmol-2015-306972-76","doi-asserted-by":"crossref","first-page":"14720","DOI":"10.1073\/pnas.97.26.14720","article-title":"Direct isolation of human central nervous system stem cells","volume":"97","author":"Uchida","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-306972-77","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1167\/iovs.13-12860","article-title":"Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration","volume":"54","author":"Cuenca","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-78","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1460-9568.2011.07970.x","article-title":"Transplantation of human central nervous system stem cells\u2014neuroprotection in retinal degeneration","volume":"35","author":"McGill","year":"2012","journal-title":"Eur J Neurosci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-79","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1167\/iovs.14-15114","article-title":"Polarization-sensitive optical coherence tomography and conventional retinal imaging strategies in assessing foveal integrity in geographic atrophy","volume":"56","author":"Sayegh","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306972-80","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/bjophthalmol-2014-305195","article-title":"A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy","volume":"98","author":"Sayegh","year":"2014","journal-title":"Brit J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306972-81","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2014.05.026","article-title":"A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy","volume":"158","author":"Simader","year":"2014","journal-title":"Am J Ophthalmol"}],"updated-by":[{"DOI":"10.1136\/bjophthalmol-2015-306972corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000}}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-306972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T18:44:50Z","timestamp":1653504290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-306972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/bjophthalmol-2015-306972"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306972","relation":{"correction":[{"id-type":"doi","id":"10.1136\/bjophthalmol-2015-306972corr1","asserted-by":"object"}]},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}